| [Clostridium] leptum| ATCC 29065| CCUG 48287| Clostridium leptum| Clostridium leptum Moore et al. 1976 (Approved Lists 1980)| DSM 753
Fermentation of Dietary Fibers: Clostridium leptum is known to be involved in the fermentation of complex carbohydrates and dietary fibers in the colon. This process produces short-chain fatty acids (SCFAs), which can have positive effects on gut health.
Butyrate Production: Some Clostridium species, including members of Clostridium leptum, are associated with the production of butyrate, a short-chain fatty acid. Butyrate is known to have anti-inflammatory properties and is considered beneficial for maintaining the health of the colonic epithelium.
Microbial Balance: Clostridium leptum is part of the complex ecosystem of the gut microbiota. Maintaining a balance within the microbial community is crucial for overall gut health and can have implications for systemic health.
Immune System Regulation: The gut microbiota, including bacteria like Clostridium leptum, plays a role in modulating the immune system. A balanced and diverse microbiome is thought to contribute to immune system homeostasis.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.74 | 0 | 0 | 10 | 11164 | 0 | 3757 | 656.1 | 210 | 1582.1 | 5 | 669 | 0 %ile | 100 %ile |
thorne | 3.45 | 0 | 1 | 1 | 1 | 1 | 1 | 0 %ile | 99 %ile | |||||
thryve | 90.79 | 1590 | 64 | 1898 | 0 | 12978 | 1542.9 | 542 | 5834.2 | 0 | 2352 | 8 %ile | 90.4 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSightRdp | 28.125 % | 0.02 % | 0.026 % | 9.0 | 32 |
CosmosId | 71.875 % | 0.125 % | 0.246 % | 23.0 | 32 |
custom | 8.475 % | 0.015 % | 0.014 % | 5.0 | 59 |
Medivere | 100 % | 0.048 % | 0.079 % | 7.0 | 7 |
SequentiaBiotech | 50 % | 0.03 % | 0.034 % | 18.0 | 36 |
Thorne | 1.136 % | 0 % | % | 1.0 | 88 |
Thryve | 89.732 % | 0.151 % | 0.539 % | 1241.0 | 1383 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.